Can the Referring Surgeon Enhance Accrual of Breast Cancer Patients to Medical and Radiation Oncology Trials? The Enhance Study | Zendy

Angel Arnaout | Zendy; Iryna Kuchuk | Zendy; Nathaniel Bouganim | Zendy; Gregory R. Pond | Zendy; S. Verma | Zendy; Roanne Segal | Zendy; Susan Dent | Zendy; S. Gertler | Zendy; X. Song | Zendy; Femina Kanji | Zendy; Mark Clemons | Zendy

Open Access

Can the Referring Surgeon Enhance Accrual of Breast Cancer Patients to Medical and Radiation Oncology Trials? The Enhance Study

Author(s) -

Angel Arnaout,

Iryna Kuchuk,

Nathaniel Bouganim,

Gregory R. Pond,

S. Verma,

Roanne Segal,

Susan Dent,

S. Gertler,

X. Song,

Femina Kanji,

Mark Clemons

Publication year - 2016

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.23.2394

Subject(s) - medicine , breast cancer , accrual , radiation oncology , alternative medicine , clinical trial , oncology , medical physics , radiation therapy , family medicine , cancer , pathology , earnings , accounting , business

The accrual rate to clinical trials in oncology remains low. In this exploratory pilot study, we prospectively assessed the role that engaging a referring surgeon plays in enhancing nonsurgical oncologic clinical trial accrual.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research